Even though the explosion of coronavirus cases in China has triggered global concerns, India has maintained that there is no need to panic in view of the extensive vaccine coverage. The government has, however, urged people to stay alert and follow COVID-appropriate behaviour
COVID-19: Fresh push to booster shots for adults; focus this time on mix-and- match doses
PM Modi to review Covid related situation in country at high-level meeting
The meeting comes a day after Union Health Minister Mansukh Mandaviya reviewed the situation and asked people to follow Covid-appropriate behaviour, including wearing masks in crowded places, and getting vaccinated.
New Covid outbreak in China: India Inc says no need to panic yet
Subhrakant Panda, the newly-appointed president of the industry association FICCI, said there is no need for panic yet but alertness is certainly called for, and that the Indian economy and corporates have the depth and resilience to withstand any “short and sharp” disruption to the global supply chain.
How the Federal spending plan hit a snag on plans to relocate the FBI building
A fight between Virginia and Maryland lawmakers over a new location for the F.B.I. headquarters held up a 4,155 page must-pass government funding measure.
Low demand, rise in raw material prices key problems of MSMEs: Survey
The report by Bhartiya Yuva Shakti Trust (BYST) also said that though markets have stabilised, about 57 per cent of the units that participated in the survey are struggling to get new orders for their merchandise.
Airport project will hit rural economy, farmers tell Tamil Nadu govt
The flow of water of a natural water channel, that carries surplus flood waters to Kosasthalai river, would be prevented leading to inundation of 30 surrounding villages and #39;incalculable farm and economic losses#39; considering flooding.
Tawang to get more mobile towers for better connectivity after India-China clash
The development came after the India-China clash at Yangtse on December 9.
Govt to step up COVID surveillance as cases increase elsewhere
India has reported the most COVID cases in the world after the United States but its tally of confirmed infections has fallen sharply in the past few months.
Indian pharma sector set for #39;volume to value leadership#39; journey in 2023
While RD investment, market competitiveness, regulatory scrutiny, and domestic price regulations are expected to shape the growth of generics and injectable products, concerns such as price control and customs duties on medical equipment will continue to bother the healthcare industry in 2023.
Government urges private vaccine makers to develop vaccine against KFD
The only vaccine against Kyasanur Forest Disease, which strikes hundreds along the Western Ghats every year and kills many of them, has become ineffective over the decades